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Summary Exposure of the breast to ionising radiation increases the risk of breast cancer, especially among
young women. However, some issues remain controversial, for instance the shape of the dose-response curve
and the expression of time-related excess. The main purpose of this report was to examine the dose-response
curves for radiation-induced breast cancer formulated according to radiobiological target theories. Another
purpose was to analyse the time-related excess of breast cancer risk after exposure when dose and age at first
exposure were held constant. Breast cancer incidence was analysed in a cohort of 3090 women diagnosed with
benign breast disease during 1925-61 (median age 37 years). Of these, 1216 were treated with radiation
therapy. The dose range was 0-50 Gy (mean 5.8 Gy). The incidence rate as function of dose was analysed
using a linear-quadratic Poisson regression model. Cell-killing effects and other modifying effects were
incorporated through additional log-linear terms. Additive and multiplicative models were compared in
estimating the time-related excess. The analysis, which was based on 278 breast cancer cases, showed a linear
dose-response relationship at low to medium dose levels with a cell-killing effect of 5% Gy-' (95% confidence
interval 2-9%). For a given absorbed dose and age at first exposure the time-related excess was proportional
to the background rates with a suggestion that the excess remains throughout life.
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It is well known that exposure of the breast to ionising
radiation increases the risk of subsequent breast cancer,
especially among young women (Baral et al., 1977; Land et
al., 1980; Shore et al., 1986; Hildreth et al., 1989; Miller et
al., 1989; Boice et al., 1991; Tokunaga et al., 1994). Accord-
ing to radiobiological target theories, the cancer risk is
expected to increase approximately linearly at low doses with
an upward curvature at medium dose levels (UNSCEAR,
1993). Simultaneously there is a potential competing effect of
cell killing that should negatively modify the response at high
dose levels (UNSCEAR, 1993).
The main purpose of this report is to present statistical
analyses of models for dose-response curves of, the men-
tioned type. The data were from a previously described
cohort study (Mattsson et al., 1993). The cohort consisted of
3090 women who presented with clinical signs and symptoms
of benign breast disease from the 1920s until the 1950s. Of
these, 1216 were treated with radiotherapy. The absorbed
dose ranged from 0 to about 50 Gy.
When estimating the lifetime excess risk of radiation-
induced breast cancer it is important to determine the risk
pattern over time since exposure and/or by attained age
(UNSCEAR, 1988; BEIR-V, 1990). Another purpose of this
report is, therefore, to describe the excess risk over time. The
analyses were done for a given dose and age at first exposure
pattern. Excess additive risk and excess relative risk models
with and without time-varying risk estimates were compared.
In models without time variation the additive model pro-
duces excess absolute risks that are constant irrespective of
the background rates, whereas the relative risk model prod-
uces excess risks that are proportional (relative) to the back-
ground rates.
Understanding dose and time patterns as well as depend-
ence on age at first exposure is important in evaluations of
the benefit of mammographic screening or of post-operative
radiation therapy for early-stage breast cancer.
Materials and methods
Materials
The patients, methods of follow-up, radiation techniques,
methods of determination of absorbed dose, absorbed doses
and results focusing on age at first exposure and time since
first exposure were published in a previous report (Mattsson
et al., 1993). The cohort consisted of 1216 exposed and 1874
unexposed women who presented with clinical signs/
symptoms of benign breast disease during the period
1925-61. The clinical diagnoses were fibroadenomatosis
(93%), acute mastitis (4%) or chronic mastitis (3%). The
women had no previous history of breast cancer and there
was no suspicion of breast cancer or a precancerous lesion at
the time of diagnosis. For instance, women with bloody
discharge from the nipple or a history of atypical epithelial
proliferation at biopsy were excluded. Patients were also
excluded if the available follow-up information showed that
they were diagnosed with breast cancer before 1958. The
exposed women were irradiated at the Department of
Radiotherapy, Karolinska Hospital. The unexposed women
had been referred to that same institution, but had not
received radiation therapy. The median age at first exposure
and/or diagnosis was 40 years (range 8-74 years) for the
exposed patients and 36 years (range 10-78 years) for the
unexposed.
To determine end point data in the cohort, the com-
puterised files were linked with the Swedish Cancer Register
to obtain the breast cancer cases, the Swedish Cause of
Death Register to obtain the dates of death and the National
Population Register to obtain the dates of emigration.
To determine the absorbed dose to each individual breast,
the radiation therapy was simulated according to the original
treatment charts using a Randophantom. Thermoluminescent
dosimetry lithium fluoride (LiF) discs were placed in the
phantom and radiation was given according to the different
treatment techniques that had been used according to the
patients' records. The accuracy of the determined absorbed
dose in the Randophantom was ± 10%. As the medical
records did not provide information about the size of the
breast, an average size was estimated from ICRP-23 (1975).
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1995In 83% of the treated patients in whom the whole breast
was irradiated, a tangential technique with opposed beams
was used, with an angulation of the beams from the horizon-
tal direction. When only a part of the breast was treated
(17% of the treated patients), the beam was medial or lateral
to the breast or perpendicular to the chest wall. For these
breasts the mean absorbed dose was calculated by the mul-
tiplication of the average absorbed dose in the primary
irradiated volume and the ratio of the primary irradiated
volume to the total volume of the breast.
The average total mean absorbed dose to 2432 exposed
breasts was 5.84 Gy (range 0.003-50.14 Gy). The lowest
values relate to the contralateral breast in patients who only
received treatment to the axilla.
In the previously published study (Mattsson et al., 1993)
the overall radiation-associated relative risk (RR) was 3.58
[95% confidence interval (CI) 2.77-4.63]. There was a
positive log-linear association between dose and RR with a
levelling off at high doses. The RR decreased with increased
age at first exposure, but was still increased at ages above 40
years. The effect over time showed a wave-like pattern with a
maximum at about 25 years after first exposure.
There was no statistically significant differences in the RR
of subsequent breast cancer between women with different
clinical diagnoses of benign breast disease. An age- and
calendar time-adjusted RR of 1.16 for untreated breasts
among the exposed cohort (mean dose 0.27 Gy) vs breasts in
the unexposed cohort indicated that the two cohorts prob-
ably had roughly the same background risk. The time
between the first and last treatment-adjusted for dose-did
not significantly influence the RR.
This report contains, in contrast to the previous report
(Mattsson et al., 1993), results from analyses of the
dose-response relationship according to radiobiological
models. Moreover, a comparison between models with inter-
nal and external reference rates was done to scrutinise the
earlier proposed time wave (Mattsson et al., 1993). Intrinsic
to the time wave issue is the comparison of which of the two
models-additive, or relative risk-best describes the time
excess of breast cancer after exposure of the breast to ionis-
ing radiation.
Statistical methods
All analyses in this report were restricted to the first primary
breast cancer. Of the three synchronously diagnosed bilateral
breast cancer cases, one was randomly chosen to represent
the first primary breast cancer. It was common that the
absorbed dose in the left and right breasts of an individual
differed considerably. To permit meaningful dose-response
analyses, the breast was, therefore, defined as the carrier of
risk. Breast-years were calculated from 1 January 1958, or
from date of diagnosis of benign breast disease for those
diagnosed later, to date of diagnosis of breast cancer, to date
of death, emigration or to 31 December 1987. The contra-
lateral breast was censored at the date of diagnosis of the
first primary breast cancer. Data covering the first 5 years
after diagnosis of benign breast disease were not included in
the analyses to avoid inclusion of preclinical cases of breast
cancer. The program PYRS (Coleman et al., 1989) was used
for the breast-year calculation.
Information about the number of breast cancer cases dur-
ing the period from 1958 to 1987 was obtained by linking the
computer files with the Swedish Cancer Register. This
register was established on 1 January 1958. Each new
primary tumour is recorded according to the ICD-7 (1957) as
a separate case. Data indicating tumour laterality were
obtained from the original notifications (filed at the Swedish
Cancer Registry) for cases that occurred before 1970.
Thereafter, such data were available from the registry in
computerised form.
Analyses were done with both internal and external
incidence rates. The external rates were from the female
population in Stockholm, since most of the patients were
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residents of that region. Models based on external rates were
primarily used to evaluate the stability of the internal back-
ground rates, especially over time since first exposure. The
expected numbers of cases, which were used in the external
analyses, were calculated by multiplying age- and calendar
year-specific breast-years by the breast-specific incidence
rates and then summed. The breast-specific incidence rates
were based on the first diagnosed primary breast cancer for
each affected woman in the Stockholm population. However,
such rates can only be computed based on computerised data
for the period 1970 to the present. For the period 1958-69
breast-specific incidence rates had to be estimated. This was
done assuming that the age- and breast-specific relative dist-
ributions between left and right breast during 1958-69 were
identical to the corresponding distributions for the period
1970-87. The standardised incidence ratio (SIR) was defined
as observed over expected number of cases.
Most inferences were by excess relative risk (ERR) models
of the form:
AA,CAB {1 +f,(D) Exp[f2(D)] Exp[f3(E, T, A,)]}
The background rates A were in all analyses classified for
A = attained age during follow-up (ten categories),
C = calendar period (three categories) and B = age at diag-
nosis of benign breast disease (seven categories). AA,C values
were in the external analyses the incidence rates of the female
population of Stockholm. In the internal analyses the back-
ground incidence rates were estimated within the cohort
itself. The termAB accounts for the dependence of back-
ground rates on age at diagnosis of benign breast disease.
The linear-quadratic functionfi(D) was generally formulated
as c1D + a2D2, where D denotes total mean absorbed dose
(referred to as dose) to the breast. The dose variable was
categorical quantitative and treated as a continuous variable.
The assigned values were the mean doses from the 19
categories given in Table I. In the aim of estimating an SIR
for the exposed cohort and dose =0, a cohort indicator
variable was incorporated in the linear part of the external
model. The first log-linear term,f2(D), was used to model the
potential modification of cell killing on the effect estimated
byf(D). The functionf2 could potentially comprise D and/or
D2 (dose, defined as above). The second log-linear term f3(E,
T, A), was incorporated in the model to take account of dose
effect modifiers. This means that the shape of the
dose-response relationship is taken to apply when the
variables inf3 are held constant. E was age at first exposure
with seven categories, T time since first exposure with seven
categories and A attained age (i.e. age at risk) with ten
categories. T and A were always incorporated after E and
were therefore not allowed to be in the same model depen-
ding on the restriction A = E+ T. When E, T and A were
coded as categorical quantitative variables, the mean values
were assigned to the different categories.
In one model, test for curvature in the ERR with time
since first exposure was tested by the term 1n2(T/25) in f3
with T categorical quantitative. This non-linear form was
chosen because it had been used to describe the time
dependence of the RR in previously published reports on
radiation-induced breast cancer (BEIR-V, 1990; Mattson et
al., 1993).
Analogous excess additive risk (EAR) models of the form
A,CAB+fJ(D) Exp[f2(D)] Exp[f3(E, T, A)]
were also fitted and compared with ERR models. The EAR
was expressed as the number of excess cases per 10 000
breast-years.
When the EAR and ERR models were compared, the
background rates were modelled both by categorical vari-
ables and by categorical quantitative variables. When age at
diagnosis of benign breast disease and calendar period were
formulated as categorical quantitative variables, the assigned
values were consecutive integers from 1 onward. Categorical
quantitative attained age was assigned values as above. Risk
estimates for categorical quantitative background rates mod-
els are presented in the results section. For comparison
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Table I Number of breast-years, number of breast cancer cases, and relative risk
(RR) by mean absorbed dose to the breast
Dose (Gy) Mean dose (Gy) Breast-years Cases RRa
0 0 92,785 95 1.00
0.003-0.09 0.065 5,095 4 0.69
0.10-0.19 0.149 4,614 8 1.49
0.20-0.34 0.276 5,334 6 1.13
0.35-0.49 0.392 5,613 10 2.08
0.50-0.99 0.684 2,320 3 1.40
1.00-1.99 1.423 1,394 4 2.62
2.00-2.99 2.487 1,878 12 5.66
3.00-3.99 3.628 2,781 14 4.03
4.00-4.99 4.451 1,614 14 7.39
5.00-5.99 5.535 1,770 9 4.24
6.00-6.99 6.520 1,004 8 7.45
7.00-7.99 7.584 1,417 13 7.31
8.00-8.99 8.352 1,120 7 5.95
9.00-9.99 9.569 817 5 6.25
10.00-11.99 11.250 2,929 16 5.62
12.00-13.99 13.121 1,404 7 5.29
14.00-15.99 15.266 4,973 20 4.75
> 16.00 24.239 2,893 23 8.81
Total exposure 5.840 48,970 183 3.53
aBackground incidence rates modelled by categorical quantitative attained age,
calendar period and age at diagnosis of benign breast disease.
Table II Comparison between linear, quadraticandlinear-quadraticexcessrelativeriskmodelsand thesaturated excessrelativeriskmodela fortwo
different truncations of dose. Internal reference
Dose truncation: <3 Gy Dose truncation: <S Gy
Difference in Difference in x2-based Difference in Difference in x2-based
Model no. Deviance deviance df. P-value Deviance deviance df. P-value
1. Saturated model 496.64 - - - 624.89 - - -
2. 1 +alID 499.74 3.10 6 0.80 630.44 5.55 8 0.70
3. 1 + 21D2 500.01 3.37 6 0.76 635.31 10.42 8 0.24
4. 1 +al2D +a22D2 499.13 2.49 5 0.78 630.35 5.45 7 0.60
aBackground incidence rates modelled by categorical quantitative attained age, calendar period and age at diagnosis of benign breast disease.
Saturated model dose categories as in Table I.
estimates from categorical background rates models are pres-
ented in the Appendix.
For an evaluation,of the linear-quadratic form f, (D)=
a,D + 2D2, the dose range was constrained to the subset
<5 Gy. This was done to reduce the effects of cell killing on
the estimates of otx and a2. The form of the dose-response
relationship was analysed for two truncated dose intervals,
<3 Gy and <5 Gy. The best-fitting form of fiD) in the
subset <5 Gy was then assumed to apply when models
incorporating the log-linear terms were fitted to the uncons-
trained dose range 0-50.14 Gy.
Poisson regression models were fitted using the program
AMFIT (Preston et al., 1988-93). Estimation of parameters
was done by maximum-likelihood methods. Differences in
deviance, a measure of unexplained variability, were used to
compare nested Poisson regression models. Change in dev-
iance between two nested models is approximately x2 dist-
ributed, with degrees of freedom equal to the difference in
the number of parameters in the two models. Confidence
intervals were computed by likelihood-based methods.
The number of breast-year-Gy (BY-Gy) was calculated
as the number of breast-years times the mean absorbed dose
for the different cells of the frequency table to which the
models were fitted. The estimated number of excess cases per
10 000 BY-Gy was calculated as a ratio of two sums: the
sum of the differences between the number offitted cases and
the number of fitted background cases and the sum of the
number of 10000 BY-Gy.
Results
The total number of observed breast cancer cases was 278, of
which 95 were in the unexposed cohort. In the analyses of
the dose-response relationship for doses <5 Gy, 75 cases
were from the exposed cohort, of which 47 were exposed to
<3 Gy (Table I). For both these truncation points the model
linear in dose provided the best fit (Table II). There was no
loss of fit when the linear model was compared with a
saturated model for categorised dose. For the internal
reference ERR model, the estimate of all, the linear effect of
a unit change of dose (in Gy) was 1.63 (95% CI 0.77-2.89)
and 1.31 (95% CI 0.79-2.04) for the <3Gy and <5Gy
truncation respectively. The estimates were insensitive to the
use of internal or external incidence rates (data not shown).
Cell killing
As shown in Figure 1, the increase in the RR levelled off at
high doses. This effect was best described by a log-linear term
with an effect estimate of 5% Gy-1 (P<0.0001; 95% CI
2-9%). Other tested possibilities included a log-quadratic
term and a log-linear-quadratic term. The fit with a log-
quadratic term was slightly worse with the same degrees of
freedom, compared with the fit with a log-linear term. The
log-linear-quadratic term did not give meaningful estimates
owing to collinearity. The estimate of the corresponding
parameter correlation coefficient was - 0.97.
Age atfirst exposure
The estimated ERR per Gy decreased with increasing age at
first exposure (Appendix). Without loss of fit this decrease
could be formulated as a log-linear trend [x2(5) = 6.3;
P= 0.28] with an estimate of - 6% per year of increased age
at first exposure (95% CI - 10% to - 2%).
The timepattern ofthe excess risk
The crude age-specific incidence rates for the unexposed
cohort followed closely the incidence rates for the female
population of Stockholm (Figure 2). The estimated increasesRadiation-induced breastcancer
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Figure 1 Dose-response curves: dose category-specific RR from
Table I and fitted RR for breast cancer for three ages at first
exposure from internal model RR = I + 0.69D Exp[ - 0.054D]
Exp[ - 0.060(E - 40)].
Figure 2 Logarithm of crude breast cancer incidence rate per
10 000 breast-years by attained age for exposed and unexposed
cohorts, and Stockholm female population 1958-87.
TableIHI Test forheterogeneitywith time since firstexposurewithin three ageatfirstexposuregroups. The test
was done with ERR modela Ica,D Exp{PD} where t is time since first exposure interval
Age atfirst Time sincefirst exposure (years) Testfor Testfor
exposure 5-19 20-29 30-39 > 40 heterogeneity curvatureb
(years) Reference a], est. cc2 est. aC3 est. CX4 est. X2 (3) (P) X2 (1) (P)
<30 Internal 4.44 3.14 1.91 1.78 1.39 (0.71) 0.003 (0.96)
External 3.61 2.33 2.19 2.75 0.62 (0.89) 1.02 (0.31)
30-39 Internal 0.91 1.56 1.03 0.22 6.71 (0.08) 5.96 (0.015)
External 0.58 0.63 0.76 0.58 0.42 (0.94) 0.20 (0.66)
> 40 Internal 0.29 0.47 0.36 0.53 0.70 (0.87) 1.36 (0.24)
External 0.16 0.38 0.30 0.44 2.36 (0.50) 2.32 (0.13)
aBackground incidence rates were classified on attained age, calendarperiod and age at diagnosis ofbenign
breast disease. 'Test function: W = In2(T/25) in ERR model ccDExp{PD}Exp{TW}. T was categorical
quantitative.
Table IV Comparison between fit of internal reference multiplicative model and internal reference additive model
Variablesa Multiplicative (ERR) model Additive (EAR) model
Difference Difference >2-based Difference Difference x2-based
Model no. Deviance in deviance in df P-value Deviance in deviance in df P-value
Background (A)b 1334.34 - - - 1334.34 - - -
Linear term, f, (.)
1.D 1183.28 151.06 1 <0.0001 1206.48 127.86 1 <0.0001
Log-linear term, f2 ()
2. Model 1 +D 1164.64 18.64 1 <0.0001 1181.99 24.49 1 <0.0001
Log-linear term, f3 (.)
3. Model 2 +E 1154.20 10.44 1 0.001 1163.00 18.99 1 <0.0001
4. Model 3 +Tc., 1149.40 4.80 3 0.187 1157.31 5.69 3 0.128
5. Model 3 +Acat 1152.64 1.56 3 0.668 1151.36 11.64 3 0.009
6. Model 3 +A 1154.22 8.78 1 0.003
aD, absorbed dose; E, age at first exposure, categorical quantitative; T,,t, categorical time since first exposure (5-19, 20-29, 30-39 and
40 years); Act, categorical attained age (<55, 55-64, 65-74, ) 75 years); A, categorical quantitative age at risk centred to 65 years of
age. bBackground rates (A) modelled by categorical quantitative attained age, calendar period and age at diagnosis of benign breast
disease.
per year of attained age were 3.0% and 3.3% respectively.
No significant difference in the increase between the exposed
and unexposed women was observed (P = 0.38), indicating a
time-constant multiplicative effect of exposure on the back-
ground rates. Similarly, when the ERR with time was
analysed in the model, holding dose and age at first exposure
constant, no persistent heterogeneity or curvature was
observed (Table III). A statistically significant curvature was
only observed in the 30-39 year age at first exposure group
when using the internal reference. However, the curvature
disappeared when the external reference was used.
ERR and EAR models
In a comparison between the multiplicative (ERR) model
and the additive (EAR) model, both with internal reference,
the former gave a slightly more parsimonious description of
the data (Table IV). Model 3, with dose and age at first
exposure, was the best-fitting multiplicative model. Neither
the general test for a modifying effect of time since first
exposure nor age at risk was significant (P= 0.19 and
P = 0.67 respectively). For additive risk, model 6 with dose,
age at first exposure and age at risk gave the best fit.
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Estimates of excess risks were invariant to the specification of
the background rates model, i.e. irrespective of inclusion of
categorical or categorical quantitative variables (Appendix).
The estimate of the best-fitting ERR model (Table IV,
model 3) with internal reference was
ERR = 0.69D Exp[- 0.054D] Exp[- 0.060 (E- 40)]
(0.202) (0.017) (0.017)
The number within parentheses is the standard error of the
estimate. Using the square of dose instead of dose in the
linear part of the model gave a slightly worse fit (change in
deviance - 10.60; same degrees of freedom). There was no
significant interaction between dose and age at first exposure
(P = 0.78). The observed and fitted number of cases from
model 3 are shown in Figure 3 for dose, age at first exposure
and attained age (age at risk).
In figure 1 the RR = 1 + ERR was plotted for three ages
at first exposure together with the dose category-specific RRs
from Table I. The difference in deviance between the ERR
model above with categorical quantitative dose variable and
the model with dose category-specific RRs was non-
significant [X2(15) = 8.44; P = 0.91]
The ERR model based on external rates gave similar
estimates as the internal model above:
ERR = 0.67D Exp[- 0.053D] Exp[- 0.063 (E- 40)]
(0.191) (0.017) (0.018)
There was no significant difference between the background
rates for the exposed and the unexposed cohorts [X2 (1) =
0.85; P = 0.36]. The estimated SIR for the exposed cohort
was, for dose equal to 0, 0.93 (or ERR = - 0.07; 95% CI
< - 0.17-0.25). For the unexposed cohort the SIR was 1.07
(or ERR= 0.07; 95% CI - 0.13 to 0.30).
The estimates of the best-fitting EAR model (Table IV,
model 6) with internal reference was
EAR = 6.69D Exp[- 0.054D] Exp[- 0.083(E - 40) + 0.033
(A - 65)]
(1.713) (0.017) (0.014) (0.011)
The linear effect (6.69) was expressed as the excess number of
cases per 10 000 breast-years. There was no significant
interaction between age at first exposure and dose (P = 0.66),
between age at risk and dose (P _ 0.62) or between age at
first exposure and age at risk (P = 0.52). The EAR model
with external reference showed similar estimates (not shown).
The estimated excess number of cases per 10000 BY-Gy
restricted to the dose range <5 Gy was calculated with the
two presented models with internal reference and the best-
fitting model based on external reference. All three models
gave similar estimates, showing increasing number of excess
cases per 10 000 BY-Gy with time after first exposure (Table
V). For the multiplicative ERR models the increasing excess
with time was an implicit effect of the increasing background
rates with attained age. The corresponding estimated excess
of cases per 10 000 BY-Gy calculated for the entire dose
range, 0-50 Gy, showed a similar pattern. However, owing
to the cell-killing effect, these estimates were lower (data not
shown).
Discussion
The main purpose of this study was to analyse the
dose-response relationship between absorbed dose in the
breast and the subsequent risk of breast cancer among
women treated for benign breast disease. The principal excess
risk dose-response model was formulated according to
theories in radiobiology as a product of two functions of
dose. The first is a linear-quadratic function describing the
increasing carcinogenic effect with dose. The second is a
log-linear function describing the competing effects of carc-
inogenicity and cell killing.
The linear-quadratic part cx,D + t2D2 was analysed first. To
decrease the influence ofcell killing on the estimates, the dose
range was truncated to levels <5 Gy. The linear model gave
a lower deviance than the quadratic model, but the difference
was generally small. Extending a linear or a quadratic model
into a linear-quadratic model resulted in only a minor in-
crease in the explanatory value. Hence, on statistical
grounds, the choice was between a linear model and a quad-
ratic model.
Although the possibility of a pure quadratic model could
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Table V Estimated excess number of cases per 10000 breast-year-Gy
(BY-Gy) by age at first exposure and years since first exposure. Comparison
between internal and external reference. Dose range <5 Gy.
Age atfirst Estimated excess no. per 10'
exposure Reference BY-Gy Years sincefirst exposure
(years) model' 5-19 20-29 30-39 40-61
<30 Internal, EARb 10.4 12.8 17.2 24.0
Internal, ERRC 8.3 11.3 17.5 28.5
External, ERRd 4.9 14.3 22.7 29.8
30-39 Internal, EARb 5.6 7.5 10.2 14.2
Internal, ERRC 4.5 6.7 10.6 17.0
External, ERRd 6.8 8.9 12.1 16.0
>40 Internal, EARb 3.4 4.5 6.1 8.2
Internal, ERRC 2.8 4.1 6.4 9.5
External, ERRd 3.4 4.7 6.2 7.8
aBackground ratesAmodelled by attained age, calendar period and age at
diagnosis of benign breast disease. bEstimates based on additive excess risk
model by internal reference: k + 6.69D Exp[ - 0.054 D]Exp[ - 0.083
(E - 40) + 0.033 (A - 65)]. Assume T= A - E, where T= years since first
exposure, A = age at risk and E= age at first exposure. cEstimates based on
excess relative risk model by internal reference: A{1 + 0.69D Exp[ - 0.054D]
Exp[ - 0.060(E- 40)]}. dEstimates based on excess relative risk model by
external reference: A{1 + 0.67D Exp[- 0.053D] Exp[ - 0.063(E- 40)]}.
Table VI Estimated excess relative risks at I Gy for breast cancer by age at first
exposure in four different studies according to number of fractions
Low number offractions High number offractions
Age at Age at
first first Massachusetts Canada
exposure A-bomb Present exposure fluoroscopy fluoroscopy
(years) survivorsa stud? (years) study' stud/
0-9 3.21 - 10-14 1.28 3.14
10-19 2.19 2.93 15-24 0.71 0.77
20-39 1.25 1.19 25-34 0.34 0.25
40 0.48 0.46 > 35 0.16 0.10
'Incidence rates (Tokunagaetal., 1994). ERR at 1 Sv.blncidence rates based on
ERR = 0.69D Exp[ - 0.054D1 Exp[ - 0.060(E- 40)]. ERR calculated for each
class midpoint. In the last open class ERRwas calculated for age at first exposure
(E) equal to 46 years (breast-year weighted mean in that category). cIncidence
rates. EstimatesbasedonthemodelERR = 0.708D Exp[ - 0.0744(E - 20)] (Boice
et al., 1991). ERR calculated for each class midpoint. In the last open class ERR
was calculated for age at first exposure (E) equal to 40 years. dMortality rates
(Miller et al., 1989). Estimates given 24 years after first exposure.
not be excluded on statistical grounds, the linear model
seems more plausible. A quadratic model without a linear
component implies, according to microdosimetric theory,
that the target for the radiation damage is larger than a
single cell. This is not the common view of radiobiologists
today. The working hypothesis of the mechanisms for car-
cinogenesis is that it is of single-cell origin (UNSCEAR,
1993). Also, the conclusion of a linear effect in the low-dose
region accords with most other breast cancer studies in this
field (Land et al., 1980; Shore et al., 1986; Miller et al., 1989;
Boice et al., 1991; Tokunaga et al., 1994).
At dose levels above 5 Gy a cell-killing effect became
obvious (Figure 1). This effect was best described by a log-
linear dose term. Cell-killing effects have been documented in
some other studies, as for example in the New York Mastitis
Study (Shore et al., 1986), in which a significant downward
curvature was observed at doses > 3 Gy. Other studies have
not found this effect, but they have generally little inform-
ation at high dose levels (Miller et al., 1989; Boice et al.,
1991; Tokunaga et al., 1994). In this study the cell-killing
effect was estimated to be about 5% Gy-' (P<0.0001, 95%
CI 2-9%).
In our previous analysis (Mattsson et al., 1993) we
observed a statistically significant wave curvature in the ERR
with time since first exposure. In this report there was no
such observation. There are at least two reasons for this
discrepancy. Firstly, the internal background rates were
modelled differently and more thoroughly. Instead of time
since diagnosis of benign breast disease, finely classified
attained age and calendar period variables were used. The
changed interpretation was confirmed by a model based on
the more stable external rates from the first primary breast
cancers for the female population of Stockholm. Secondly,
the different model structure that was used here contributed
to the reverse conclusion. Consequently, this report does not
support the BEIR-V report (1990), which proposed a cur-
vature with time for the ERR. Instead it accords with the
latest RERF report (Thompson et al., 1994) and the latest
published breast cancer studies (Shore et al., 1986; Boice et
al., 1991; Tokunaga et al., 1994) except for the Canadian
Fluoroscopy Study (Miller et al., 1989). However, the
Canadian study was based on mortality, which might be a
less sensitive indicator of radiation effects than incidence.
The multiplicative model produced the simplest model with
only three parameters to describe the time constant ERR.
The only modifying effect, except for dose, was the decreas-
ing effect with increasing age at first exposure. This model
implies that the excess number of induced breast cancer cases
increases at the same rate by age at risk as the background
rates. The additive model gave an explicit estimate of this
increase (3.3% per year). The results also indicated that there
was no need to discriminate between the multiplicative model
and the time-dependent additive model for the calculation of
the excess with time. This was illustrated in Table V, in
which the two models are seen to show similar increases in
excess number of induced breast cancer cases per 10 000
BY-Gy.
Table V shows that the excess risk was increased throughRadiation-induced breast cancer
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the time category 40-61 years after first exposure for all age
at first exposure categories. Such an increase accords with the
observation in the Massachusetts Fluoroscopy study (Boice
et al., 1991), which had a similar length of follow-up. The
observed pattern suggests that the excess risk ofbreast cancer
stays increased for the rest of life. This interpretation is
supported by the increased incidence rates among the
exposed women for attained ages above 85 years (Figure 2).
Concerns that the exposed and unexposed cohort had
different background incidence rates, potentially confounding
the risk estimates, proved to be unfounded. The analyses in
this report indicated that the exposed and the unexposed
cohort had background incidence rates similar to the
incidence rates of female population of Stockholm. In the
ERR model with external reference there was no significant
difference in the background rates between the exposed and
unexposed cohort (P = 0.36).
The relatively high excess relative risks observed for the
current cohort compared with that in the fluoroscopy studies
(Table VI) could perhaps be explained by fractionation
effects (Miller et al., 1989; Boice et al., 1991). Such effects
were not studied in this report. However, the dose per frac-
tion was comparatively high, probably inhibiting any observ-
able effect of fractionation. In the New York Mastitis Study
(Shore et al., 1986) the dose per fraction was also compar-
atively high and no effect of fractionation was observed. The
range of the dose per fraction must perhaps be considerably
wider for the effect to be detected in an individual study. In
Table VI, estimates at 1 Gy for four different age at first
exposure groups from four studies are presented. The study
of the A-bomb survivors (Tokunaga et al., 1994) and our
study are characterised by one or a few fractions for a given
dose. In contrast, the fluoroscopy studies had a given dose
delivered in about 100 fractions (Miller et al., 1989; Boice et
al., 1991). A marked difference in the ERR possibly depen-
ding on the number of fractions is observed. However, this
discrepancy could also be due to, for instance, statistical
uncertainty, bias or the scale used (additive vs multiplicative).
If indeed fractionation has an effect, it must be considered in
models for the prediction of the excess risk after exposures to
low doses distributed in many fractions. Such a fractionation
effect is important, for instance in the evaluation of the
radiation hazard from mammography screening.
To summarise, the current data set supported a linear
dose-response relationship at doses < 5 Gy. The linear effect
was, in the multiplicative model, modified by cell killing and
age at first exposure. To reflect the increasing absolute effect
by age at risk one extra parameter had to be incorporated
into the additive model to achieve the same level of goodness
of fit as provided by the multiplicative model.
In the light of these results, and if the dose-response
relationship has no threshold, as indicated by current
radiobiological knowledge (UNSCEAR, 1993), it seems
reasonable to assume that the excess relative risk increases
monotonically from very low doses, and probably from the
lowest possible dose, to medium dose levels. At high dose
levels, cell killing is the dominant factor which gives the
dose-response curve a downward slope. The excess breast
cancer risk due to radiation exposure to the breast among
adult women is sustained, in terms of risk relative to back-
ground rates, to at least 80 years of age, and probably
lifelong.
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Appendix
Internal reference models with categorical background variables
In the following table the number of breast cancers in exposed and
unexposed subjects, estimates of the linear effect, a in the ERR
model M:aiD Exp(PD) and 95% confidence intervals (CI) for a by age
at first exposure group (<30, 30-39, 40-49, > 50 years) are pres-
ented. Background incidence rates were modelled by attained age
(ten categories), calendar period (three categories) and age at diag-
nosis of benign breast disease (seven categories). The common
estimate of P was - 0.054.Radiaton-induced breastcancer
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Age at first No. of breast cancers Estimate
exposure (years) Exposed Unexposed of a
<30 56 31 2.15
30-39 61 38 0.82
40-49 51 19 0.61
>50 15 7 0.37
All 183 95 1.22
For the same specification of the background rates model
categorical quantitative ERR model was estimated to be:
ERR = 0.72D Exp[ - 0.052D] Exp( - 0.059(E - 40)]
(0.201) (0.017) (0.017)
95% CI
1.16-3.85
0.41-1.56
0.25-1.39
0.05-1.41
0.72-1.98
the
The number within parentheses is the standard error of the estimate.
.1 I .